JPRN-UMIN000041014尚未招募未知
Study of the therapeutic effects of bariatric surgery for severe obesity - Study of the therapeutic effects of bariatric surgery for severe obesity
Tottori University Faculty of Medicine, Division of Cardiovascular Medicine and Endocrinology and Me0 个研究点目标入组 20 人开始时间: 2020年8月1日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18years-old 至 65years-old(—)
- 性别
- All
入选标准
- 未提供
排除标准
- •Patients who violate any of the following are excluded from this study. 1) Diabetes patients with etiology other than type 2 diabetes 2) Patients with a history of severe ketosis, diabetic coma or precoma within the past 6 months. 3) Patients with severe infections and serious trauma 4) Pregnant women or women who may be pregnant and breast-feeding patients 5) Patients with severe liver dysfunction 6) Patients with moderate or higher renal dysfunction or end-stage renal failure on dialysis 7) Patients with heart failure (NYHA classification II-IV) 8) Patients with serious mental illness 9) Patients with a history of hypersensitivity to insulin 10) Obese patients due to abnormal endocrine hormones 11) Patients treated with steroid hormones 12) Patients who are not suitable for study participation because of medical reasons
研究者
相似试验
终止
不适用
Impact of bariatric surgery on the use of medicines and the quality of life of obese patientsQuality of lifeMedication useE02.319ObesityRBR-3czdjv7niversidade Federal do Vale do São Francisco
进行中(未招募)
不适用
Study of the effectiveness of bariatric surgery in the treatment of type II Diabetes Mellitus in patients with grade I obesityEUCTR2011-005884-25-ESServicio de Endocrinologia y Nutricion. Hospital Universitari Bellvitge
已完成
4 期
The effect of bariatric surgery on pharmacotherapy of psychotropic drugs in clinical practiceNL-OMON55606Sint Antonius Ziekenhuis40
Unknown
不适用
The effect of bariatric surgery on pharmacotherapy of psychotropic drugsNL-OMON29532St Antonius hospital
已完成
4 期
The influence of having bariatric surgery on the pharmacokinetics, safety and efficacy of the novel non-nucleoside reverse transcriptase inhibitor doravirine (LABRADOR)NL-OMON51582Afdeling Apotheek1
